Genetic-specific Effects of Fructose on Liver Lipogenesis



Status:Recruiting
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:12 - 40
Updated:3/8/2019
Start Date:January 25, 2019
End Date:December 2019
Contact:Saroja Voruganti, PhD
Email:saroja@unc.edu
Phone:704-250-5009

Use our guide to learn which trials are right for you!

The primary goal of this study is to identify a set of genotypes that increase the risk for
nonalcoholic fatty liver disease (NAFLD) and predispose individuals to increased de novo
lipogenesis (DNL) and liver fat accumulation when exposed to fructose intake. The proposed
goal will be achieved through the completion of following aims:

1. To determine the impact of prolonged exposure of fructose on hepatic lipid accumulation
in Caucasian individuals with high and low genetic risk for NAFLD,

2. to determine the impact of acute exposure of fructose on hepatic DNL, and

3. to determine the relationship between markers of DNL, liver fat accumulation and serum
concentrations of lipids, uric acid and liver function markers before and after the
fructose challenge.

BACKGROUND AND RATIONALE Non-alcoholic fatty liver disease (NAFLD) is characterized by fat
accumulation in liver cells not caused by alcohol. A leading cause of chronic liver disease
in the US, NAFLD represents a group of disorders including steatosis, nonalcoholic
steatohepatitis with fibrosis. It has substantially risen in prevalence over the last two
decades with the estimated prevalence being 20% among US adults and 25% in young adults
(18-39 years). Over 64 million individuals are believed to have NAFLD with annual medical
costs rising to more $100 billion. More common in individuals who are obese or diabetic
and/or have metabolic syndrome, NAFLD has been associated with increased cirrhosis,
liver-related mortality and hepatocellular carcinoma.

Both genetic and environmental, including nutritional, factors contribute to the onset and
progression of NAFLD. Increased consumption of sugar-sweetened, fructose-rich beverages has
been linked to NAFLD. Fructose, commonly found in soft drinks, fruit juices and energy
drinks, affects many metabolic processes, foremost being an increase in fat accumulation in
the liver and hence, NAFLD. Genome-wide and candidate gene studies have identified several
genes associated with NAFLD. However, none of these studies have shown the cumulative effects
of single nucleotide polymorphisms (SNPs) on changes in liver fat when exposed to fructose.
The results from this study can be extrapolated to larger cohorts and other ethnicities and
are therefore, expected to lay the foundation for developing personalized nutritional plans.

Inclusion Criteria:

1. Subjects 12 - 40 years

2. No history of alcohol abuse (> 7 drinks per week)

3. History of fructose intake of < 14 drinks per week

4. Caucasian ethnicity

5. BMI > 25kg/m² - 32kg/m² or 85th -99th percentile but otherwise healthy

Exclusion Criteria:

1. ages < 12 and > 40 years

2. Pregnant/lactating

3. known alcohol abuse or fructose intake > 14 drinks per week

4. not of Caucasian ethnicity

5. glucose levels > 100 mg/dL if fasting, > 140mg/dL if within 2 hours post meal and >
200 mg/dL if random sample

6. taking anti-hypertensive, anti-diabetic, uric acid and/or lipid-lowering medications

7. known diagnosis of diabetes, fructose intolerance, chronic kidney disease, NAFLD or
any liver-related disease, hypertriglyceridemia, polycystic ovary syndrome,
hypothyroidism, obstructive sleep apnea, hypopituitarism and hypogonadism

8. BMI < 25kg/m² or > 32 kg/m² or < 85th or > 99th percentile

9. Liver fat fraction >5% as per baseline MRI scan
We found this trial at
1
site
Kannapolis, North Carolina 28081
Phone: 704-250-5009
?
mi
from
Kannapolis, NC
Click here to add this to my saved trials